Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Why would a patient trust a peptide more than a statin? STAT Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,